Crossmark

Role of Image-Guided Percutaneous Needle Biopsy in the Age of Precision Medicine

Published Online: 2022-04-01

Published Print: 2022-08

Authors

Sone, Miyuki https://orcid.org/0000-0002-4597-1500
Sugawara, Shunsuke

Yatabe, Yasushi
License Information

Text and Data Mining valid from 2022-04-01

Version of Record valid from 2022-04-01
More Information

Article History

Accepted: 27 February 2022

First Online: 1 April 2022

Declarations

:

: Miyuki Sone has received research grant from Canon Medical Systems; has received honoraria for lectures from Bayer Holding, Covidien Japan, Hikari Pharmaceutical, and Canon Medical Systems; and has received consulting fee from Astellas Pharma, Guerbet Japan. Shunsuke Sugawara declares no conflict of interest. Yasushi Yatabe reported contracted studies with ArcherDx, Chugai-pharma, and Thermo Fisher Science; has received honoraria for lectures from MSD, Chugai-pharma, AstraZeneca, Pfizer, Roche/Ventana, Agilent/Dako, Thermo Fisher Science, ArcherDx, Novartis, Elli-Lily, Amgen, and Sysmex; and reported participation on Advisory Board of MSD, Chugai-pharma, AstraZeneca, Novartis, Amgen, Takeda, and Daiichi-Sankyo.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current